Literature DB >> 29936325

2017 McDonald diagnostic criteria: A review of the evidence.

N McNicholas1, M Hutchinson2, C McGuigan2, J Chataway3.   

Abstract

The diagnosis of Multiple Sclerosis (MS) has continuously evolved, allowing for an earlier and more accurate diagnosis of MS over time. The McDonald Criteria for diagnosis of MS were originally proposed in 2001, with previous revisions in both 2005 and 2010. The International Panel on Diagnosis in MS have recently reviewed the 2010 McDonald Criteria, and made recommendations for the revised 2017 McDonald Criteria. Any revisions made relied entirely on the available evidence, and not expert opinion. In this review, we provide an overview of the recent 2017 revisions to the McDonald Criteria, focusing in particular on the motivating evidence behind the recommendations made. We also review the existing research around misdiagnosis in MS, as well as areas considered to be high priorities of research, currently lacking in sufficient evidence, which may influence future diagnostic criteria in years to come. Finally, we illustrate some clinical examples, to demonstrate the impact of new diagnostic criteria on time to MS diagnosis in a real-world setting. Crown
Copyright © 2018. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29936325     DOI: 10.1016/j.msard.2018.05.011

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  8 in total

1.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

2.  Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis.

Authors:  Amy T Waldman; Leslie Benson; John R Sollee; Amy M Lavery; Geraldine W Liu; Ari J Green; Emmanuelle Waubant; Gena Heidary; Darrel Conger; Jennifer Graves; Benjamin Greenberg
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 3.042

Review 3.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

4.  Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.

Authors:  Sara Gil-Perotin; Jessica Castillo-Villalba; Laura Cubas-Nuñez; Raquel Gasque; David Hervas; Josep Gomez-Mateu; Carmen Alcala; Francisco Perez-Miralles; Francisco Gascon; Jose Andres Dominguez; Bonaventura Casanova
Journal:  Front Neurol       Date:  2019-09-23       Impact factor: 4.003

Review 5.  Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles.

Authors:  Anagha Aneesh; Alice Liu; Biji Mathew; Steven Roth; Heather E Moss; Douglas Feinstein; Sriram Ravindran
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 8.079

Review 6.  Update on pediatric optic neuritis.

Authors:  Jane H Lock; Nancy J Newman; Valérie Biousse; Jason H Peragallo
Journal:  Curr Opin Ophthalmol       Date:  2019-11       Impact factor: 3.761

7.  Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy.

Authors:  Anthea Di Rita; Daniela F Angelini; Teresa Maiorino; Valerio Caputo; Raffaella Cascella; Mukesh Kumar; Matteo Tiberti; Matteo Lambrughi; Nicole Wesch; Frank Löhr; Volker Dötsch; Marianna Carinci; Pasquale D'Acunzo; Valerio Chiurchiù; Elena Papaleo; Vladimir V Rogov; Emiliano Giardina; Luca Battistini; Flavie Strappazzon
Journal:  Cell Death Differ       Date:  2021-03-15       Impact factor: 12.067

8.  Validation of multiple sclerosis diagnoses in the Swedish National Patient Register.

Authors:  Chantelle Murley; Emilie Friberg; Jan Hillert; Kristina Alexanderson; Fei Yang
Journal:  Eur J Epidemiol       Date:  2019-09-06       Impact factor: 8.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.